OPDIVO

Google image searchProduct monograph

Active ingredient

nivolumab, 10 MG/ML

DIN: 02446634

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 100MG/10ML (SINGLE-USE VIAL)

Schedule: Prescription / Schedule D

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 23-OCT-2015

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF01 — NIVOLUMAB (ATC/DDD)

External Links for Opdivo

Search on Google

• Opdivo side effects
• Opdivo dosage
• nivolumab side effects
• nivolumab dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find opdivo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.